Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BMO

BMO Sees 'Differentiated Gene Editing Platform' For This Small-Cap Stock

BMO Capital Markets initiated the coverage on Precision BioSciences Inc (NASDAQ:DTIL) with an Outperform rating and a price target of $7. The analyst said the thesis is based on: The company's proprietary gene-editing platform, whose mechanism is differentiated in a CRISPR-dominated space, offers several advantages. A diversified pipeline. Asymmetric risk/reward skewed to the upside.…

Read How Bank Of Montreal Fared In Q2

Read How Bank Of Montreal Fared In Q2

Bank of Montreal (TSX: BMO) (NYSE: BMO)

One Analyst Cuts Disney Price Target, Another Reiterates Buy Rating: Who's Right?

One Analyst Cuts Disney Price Target, Another Reiterates Buy Rating: Who's Right?

Walt Disney Co (NYSE: DIS) was featured as the call of the day Tuesday on CNBC's "Fast Money Halftime Report." Analysts Clash: BMO reiterated Disney with a Market Perform rating and cut the price target to $140 from $175.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: Bank of Montreal Q1 Earnings

Bank of Montreal (NYSE:BMO) reported its Q1 earnings results on Tuesday, March 1, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Eli Lilly And Co

BMO Capital Markets

Bank of Montreal

Precision BioSciences

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play